(Q39431389)

11 September 2017

title

Amantadine is beneficial in restless legs syndrome (English)

1 reference

11 September 2017

5

Gwinn-Hardy K

1 reference

11 September 2017

Evidente VG

1

1 reference

11 September 2017

Adler CH

series ordinal

2

1 reference

11 September 2017

Caviness JN

series ordinal

3

1 reference

11 September 2017

Hentz JG

series ordinal

4

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

11 September 2017

1 reference

11 September 2017

volume

15

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

324-327

1 reference

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

How to help patients with restless legs syndrome. Discerning the indescribable and relaxing the restless.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

On the mode of action of amantadine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

Iron status and restless legs syndrome in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

Augmentation of the restless legs syndrome with carbidopa/levodopa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200003%2915%3A2%3C324%3A%3AAID-MDS1020%3E3.0.CO%3B2-4

10.1002/1531-8257(200003)15:2<324::AID-MDS1020>3.0.CO;2-4

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference